NCT07412769 ASMact: Study on Management of Bronchial Asthma
| NCT ID | NCT07412769 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Meyer Children's Hospital IRCCS |
| Condition | Asthma Acute |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-11-05 |
| Primary Completion | 2026-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-11-05 with a primary completion date of 2026-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
Eligibility Criteria
Inclusion Criteria: * Age between 6 and 17 years * Presentation to the emergency department with a diagnosis of acute asthma exacerbation * Evaluation in the emergency department of one of the participating centers during the study periods Exclusion Criteria: * Age \< 6 years or \> 17 years * Diagnosis other than acute asthma exacerbation * Incomplete or missing clinical data * Patients transferred from other hospitals already treated for the same episode * history of allergy to any drugs used in the protocol
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07412769 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Asthma Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07412769 currently recruiting?
Yes, NCT07412769 is actively recruiting participants. Contact the research team at grazia.fenu@meyer.it for enrollment information.
Where is the NCT07412769 trial being conducted?
This trial is being conducted at Ferrara, Italy, Florence, Italy.
Who is sponsoring the NCT07412769 clinical trial?
NCT07412769 is sponsored by Meyer Children's Hospital IRCCS. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.